RESPONSE TO TREATMENT OF CHOROIDAL NEOVASCULARIZATION IN HIGHLY MYOPIC EYES WITH DOME-SHAPED MACULA: Two Years of Follow-Up.
Journal
Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
pubmed:
18
2
2022
medline:
25
5
2022
entrez:
17
2
2022
Statut:
ppublish
Résumé
To compare the 2-year outcome to antivascular endothelial growth factor therapy for myopic choroidal neovascularization (CNV) in the eyes with or without dome-shaped macula (DSM). Data from treatment-naive myopic CNV with a 2-year follow-up were retrospectively collected and divided into two groups according to the presence of DSM. The best-corrected visual acuity was acquired at baseline, 3, 12, and 24 months. The association between visual outcomes and CNV type and area, presence of scleral-derived feeder vessel, macular atrophy, and lacquer cracks at baseline was also evaluated. Fifty-four eyes of 54 patients were included; 18 eyes (33.4%) had DSM. Choroidal neovascularization was foveal in 10 DSM eyes (55.6%) and in 30 non-DSM eyes (83.9%), P = 0.033. At baseline, the mean best-corrected visual acuity was significantly higher in the DSM group (68.33 ± 12.04 Early Treatment Diabetic Retinopathy Study letters, 20/40 Snellen) compared with the non-DSM group (57.75 ± 13.46 Early Treatment Diabetic Retinopathy Study letters, 20/72 Snellen; P = 0.007). This difference disappeared after 3 months and did not reoccur afterward. All other parameters were not significantly associated with visual outcomes. Overall, DSM does not represent a negative prognostic factor in response to antivascular endothelial growth factor therapy in myopic CNVs after 2 years. However, in DSM eyes, CNVs tend to be extrafoveal, thus ensuring a good visual prognosis from the earliest stage of the disease.
Identifiants
pubmed: 35174804
doi: 10.1097/IAE.0000000000003431
pii: 00006982-202206000-00007
doi:
Substances chimiques
Endothelial Growth Factors
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1057-1064Références
Gaucher D, Erginay A, Lecleire-Collet A, et al. Dome-shaped macula in eyes with myopic posterior staphyloma. Am J Ophthalmol 2008;145:909–914.
Zhao X, Ding X, Lyu C, et al. Observational study of clinical characteristics of dome-shaped macula in Chinese Han with high myopia at Zhongshan Ophthalmic Centre. BMJ Open 2018;8:e021887.
Caillaux V, Gaucher D, Gualino V, et al. Morphologic characterization of dome-shaped macula in myopic eyes with serous macular detachment. Am J Ophthalmol 2013;156:958–967.e1.
Liang IC, Shimada N, Tanaka Y, et al. Comparison of clinical features in highly myopic eyes with and without a dome-shaped macula. Ophthalmology 2015;122:1591–1600.
Ellabban AA, Tsujikawa A, Matsumoto A, et al. Three-dimensional tomographic features of dome-shaped macula by swept-source optical coherence tomography. Am J Ophthalmol 2013;155:320–328.e2.
Imamura Y, Iida T, Maruko I, et al. Enhanced depth imaging optical coherence tomography of the sclera in dome-shaped macula. Am J Ophthalmol 2011;151:297–302.
Yoshida T, Ohno-Matsui K, Yasuzumi K, et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 2003;110:1297–1305.
Ohno-Matsui K, Yoshida T, Futagami S, et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 2003;87:570–573.
Soudier G, Gaudric A, Gualino V, et al. Long-term evolution of dome-shaped macula: increased macular bulge is associated with extended macular atrophy. Retina 2016;36:944–952.
Wolf S, Balciuniene VJ, Laganovska G, et al. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 2014;121:682–692.e2.
Ikuno Y, Ohno-Matsui K, Wong TY, et al. Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology 2015;122:1220–1227.
Lee JH, Lee SC, Choi S, et al. Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia. Eye (Lond) 2017;31:507–508.
Cai B, Yang J, Li S, et al. Comparison of the efficacy of intravitreal ranibizumab for choroidal neovascularization due to pathological myopia with and without a dome-shaped macula. Medicine (Baltimore) 2017;96:e9251.
Ohno-Matsui K, Kawasaki R, Jonas JB, et al. International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 2015;159:877–883.e7.
Querques G, Corvi F, Balaratnasingam C, et al. Lacquer cracks and perforating scleral vessels in pathologic myopia: a possible causal relationship. Am J Ophthalmol 2015;160:759–766.e2.
Ohno-Matsui K, Akiba M, Ishibashi T, Moriyama M. Observations of vascular structures within and posterior to sclera in eyes with pathologic myopia by swept-source optical coherence tomography. Invest Ophthalmol Vis Sci 2012;53:7290–7298.
Ohsugi H, Ikuno Y, Oshima K, et al. Morphologic characteristics of macular complications of a dome-shaped macula determined by swept-source optical coherence tomography. Am J Ophthalmol 2014;158:162–170.e1.
Viola F, Dell'Arti L, Benatti E, et al. Choroidal findings in dome-shaped macula in highly myopic eyes: a longitudinal study. Am J Ophthalmol 2015;159:44–52.
Marchese A, Arrigo A, Sacconi R, et al. Spectrum of choroidal neovascularisation associated with dome-shaped macula. Br J Ophthalmol 2019;103:1146–1151.
Onishi Y, Yokoi T, Kasahara K, et al. Five-year outcomes of intravitreal ranibizumab for choroidal neovascularization in patients with pathologic myopia. Retina 2019;39:1289–1298.
Wu TT, Kung YH. Five-year outcomes of intravitreal injection of ranibizumab for the treatment OF myopic choroidal neovascularization. Retina 2017;37:2056–2061.
Ceklic L, Wolf-Schnurrbusch U, Gekkieva M, Wolf S. Visual acuity outcome in RADIANCE study patients with dome-shaped macular features. Ophthalmology 2014;121:2288–2289.
Wang L, Lin BW, Yin XF, et al. Visual acuity and size of choroidal neovascularization in highly myopic eyes with a dome-shaped macula. J Ophthalmol 2020;2020:8852156.
Ellabban AA, Tsujikawa A, Muraoka Y, et al. Dome-shaped macular configuration: longitudinal changes in the sclera and choroid by swept-source optical coherence tomography over two years. Am J Ophthalmol 2014;158:1062–1070.
Dormegny L, Liu X, Philippakis E, et al. Evolution of dome-shaped macula is due to differential elongation of the eye predominant in the peri-dome region. Am J Ophthalmol 2021;224:18–29.
Invernizzi A, Giani A, Cigada M, Staurenghi G. Retrobulbar structure visualization with enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci 2013;54:2678–2684.
Noble KG, Carr RE. Pathologic myopia. Ophthalmology 1982;89:1099–1100.
Ishida T, Watanabe T, Yokoi T, et al. Possible connection of short posterior ciliary arteries to choroidal neovascularisations in eyes with pathologic myopia. Br J Ophthalmol 2019;103:457–462.
Campochiaro PA. Molecular pathogenesis of retinal and choroidal vascular diseases. Prog Retin Eye Res 2015;49:67–81.
Wakabayashi T, Ikuno Y. Choroidal filling delay in choroidal neovascularisation due to pathological myopia. Br J Ophthalmol 2010;94:611–615.